Literature DB >> 30918960

NG2/CSPG4 in glioblastoma: about flexibility.

Gaetano Finocchiaro1, Serena Pellegatta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30918960      PMCID： PMC6556905          DOI： 10.1093/neuonc/noz055

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

Review 1.  NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.

Authors:  William B Stallcup; Weon-Kyoo You; Karolina Kucharova; Pilar Cejudo-Martin; Fusanori Yotsumoto
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

2.  The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours.

Authors:  M Chekenya; P Ø Enger; F Thorsen; B B Tysnes; S Al-Sarraj; T A Read; T Furmanek; R Mahesparan; J M Levine; A M Butt; G J Pilkington; R Bjerkvig
Journal:  Neuropathol Appl Neurobiol       Date:  2002-10       Impact factor: 8.090

3.  NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia.

Authors:  Q Gao; J Lu; Y Huo; N Baby; E A Ling; S T Dheen
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 4.  Cancer stem cells revisited.

Authors:  Eduard Batlle; Hans Clevers
Journal:  Nat Med       Date:  2017-10-06       Impact factor: 53.440

5.  Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.

Authors:  Serena Pellegatta; Barbara Savoldo; Natalia Di Ianni; Cristina Corbetta; Yuhui Chen; Monica Patané; Chuang Sun; Bianca Pollo; Soldano Ferrone; Francesco DiMeco; Gaetano Finocchiaro; Gianpietro Dotti
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

6.  Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Authors:  Jian Wang; Agnete Svendsen; Justyna Kmiecik; Heike Immervoll; Kai Ove Skaftnesmo; Jesús Planagumà; Rolf Kåre Reed; Rolf Bjerkvig; Hrvoje Miletic; Per Øyvind Enger; Cecilie Brekke Rygh; Martha Chekenya
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

Review 7.  CSPG4: a prototype oncoantigen for translational immunotherapy studies.

Authors:  Valeria Rolih; Giuseppina Barutello; Selina Iussich; Raffaella De Maria; Elena Quaglino; Paolo Buracco; Federica Cavallo; Federica Riccardo
Journal:  J Transl Med       Date:  2017-07-01       Impact factor: 5.531

8.  Differential phosphorylation of NG2 proteoglycan by ERK and PKCalpha helps balance cell proliferation and migration.

Authors:  Irwan T Makagiansar; Scott Williams; Tomas Mustelin; William B Stallcup
Journal:  J Cell Biol       Date:  2007-06-25       Impact factor: 10.539

9.  NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.

Authors:  Weon-Kyoo You; Fusanori Yotsumoto; Kenji Sakimura; Ralf H Adams; William B Stallcup
Journal:  Angiogenesis       Date:  2013-08-08       Impact factor: 9.596

10.  A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR.

Authors:  Talal F Al-Mayhani; Richard M Heywood; Vamsidhara Vemireddy; Justin D Lathia; Sara G M Piccirillo; Colin Watts
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300
  10 in total
  1 in total

1.  Disproportion in Pericyte/Endothelial Cell Proliferation and Mechanisms of Intussusceptive Angiogenesis Participate in Bizarre Vessel Formation in Glioblastoma.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Miriam González-Gómez; María-Del-Pino García; Lucio Díaz-Flores; Ibrahim González-Marrero; Julio Ávila; Pablo Martín-Vasallo
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.